Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Tinea Pedis (Athlete Foot) - Overview
Tinea Pedis (Athlete Foot) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Tinea Pedis (Athlete Foot) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Tinea Pedis (Athlete Foot) - Companies Involved in Therapeutics Development
Biolab Farmaceutica Ltda
Blueberry Therapeutics Ltd
Broda Tech LLC
DermBiont Inc
Sanotize Research And Development Corp
Tinea Pedis (Athlete Foot) - Drug Profiles
dapacozole - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DBI-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NORS-6491 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
terbifine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
terbifine hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Tinea Pedis (Athlete Foot) - Dormant Projects
Tinea Pedis (Athlete Foot) - Product Development Milestones
Featured News & Press Releases
Oct 22, 2019: DermBiont announces positive data from phase 2a clinical trial and start of phase 2b clinical trial for Athlete’s Foot with a topical live biotherapeutic
Mar 13, 2019: DermBiont begins Phase 2 clinical trial for athlete’s foot with a live bacterial topical probiotic
Nov 23, 2018: Blueberry reports positive results from Phase I/II BB2603 trial
Apr 26, 2017: Blueberry Therapeutics commence Phase I/II clinical trial of lead product BB2603
Apr 04, 2017: Mike Davies presents at the "Adaptive Designs in Clinical Trials" conference
Feb 28, 2017: Blueberry Therapeutics gains fil approval for its first clinical trial
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Tinea Pedis (Athlete Foot), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Tinea Pedis (Athlete Foot), H1 2020
Number of Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Tinea Pedis (Athlete Foot) - Pipeline by Biolab Farmaceutica Ltda, H1 2020
Tinea Pedis (Athlete Foot) - Pipeline by Blueberry Therapeutics Ltd, H1 2020
Tinea Pedis (Athlete Foot) - Pipeline by Broda Tech LLC, H1 2020
Tinea Pedis (Athlete Foot) - Pipeline by DermBiont Inc, H1 2020
Tinea Pedis (Athlete Foot) - Pipeline by Sanotize Research And Development Corp, H1 2020
Tinea Pedis (Athlete Foot) - Dormant Projects, H1 2020